RIPK4 and ovarian serous adenocarcinoma: In serous ovarian cancer, the expression of RIPK4 in high-grade cancer tissues was obviously higher than that in low-grade cancer tissues, and lymph node metastasis and late clinical stage were also significantly correlated with high RIPK4 immunological reactivity (P = 0.003, respectively).